Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress
Open Access
- 26 February 2010
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 53 (5) , 989-1000
- https://doi.org/10.1007/s00125-010-1677-0
Abstract
Aims/hypothesis Impaired nitric oxide (NO)-dependent vasorelaxation plays a key role in the development of diabetic vascular complications. We investigated the effect of hyperglycaemia on impaired vasoreactivity and a putative role therein of the AGE precursor methylglyoxal. Methods The effects of high glucose and methylglyoxal on NO-dependent vasorelaxation in isolated rat mesenteric arteries from wild-type and transgenic glyoxalase (GLO)-I (also known as GLO1) rats, i.e. the enzyme detoxifying methylglyoxal, were recorded in a wire myograph. AGE formation of the major methylglyoxal-adduct 5-hydro-5-methylimidazolone (MG-H1) was detected with an antibody against MG-H1 and quantified with ultra-performance liquid chromatography (tandem) mass spectrometry. Reactive oxygen species formation was measured with a 5-(and-6)-chloromethyl-2′7′-dichlorodihydrofluorescein diacetate acetyl ester probe and by immunohistochemistry with an antibody against nitrotyrosine. Results High glucose and methylglyoxal exposure of mesenteric arteries significantly reduced the efficacy of NO-dependent vasorelaxation (p < 0.05). This impairment was not observed in mesenteric arteries of GLO-I transgenic rats indicating a specific intracellular methylglyoxal effect. The diabetes-induced impaired potency (pD2) in mesenteric arteries of wild-type rats was significantly improved by GLO-I overexpression (p < 0.05). Methylglyoxal-modified albumin did not affect NO-dependent vasorelaxation, while under the same conditions the receptor for AGE ligand S100b did (p < 0.05). Methylglyoxal treatment of arteries increased intracellular staining of MG-H1 in endothelial cells and adventitia by fivefold accompanied by an eightfold increase in the oxidative stress marker nitrotyrosine. Antioxidant pre-incubation prevented methylglyoxal-induced impairment of vasoreactivity. Conclusions/interpretation These data show that hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation is mediated by increased intracellular methylglyoxal levels in a pathway dependent on oxidative stress.Keywords
This publication has 57 references indexed in Scilit:
- C. elegans as Model for the Study of High Glucose– Mediated Life Span ReductionDiabetes, 2009
- Role of Advanced Glycation End Products With Oxidative Stress in Resistance Artery Dysfunction in Type 2 Diabetic MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Oxidative Stress as a Major Culprit in Kidney Disease in DiabetesDiabetes, 2008
- Decreasing Intracellular Superoxide Corrects Defective Ischemia-induced New Vessel Formation in Diabetic MiceJournal of Biological Chemistry, 2008
- Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an AntioxidantHypertension, 2008
- Heat‐shock protein 27 is a major methylglyoxal‐modified protein in endothelial cellsFEBS Letters, 2006
- Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous woundsClinical Science, 2005
- α-Oxoaldehyde metabolism and diabetic complicationsBiochemical Society Transactions, 2003
- Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycationBiochemical Society Transactions, 2003